Events

CLIA (Clinical Laboratory Improvement Amendments) Waiver Applications Final Guidances

WHEN
April 14 / 3:00 PM - 4:30 PM EDT
04/14/20 3:00 PM 04/14/20 4:30 PM America/New_York CLIA (Clinical Laboratory Improvement Amendments) Waiver Applications Final Guidances United States

On April 14, 2020, the U.S. Food and Drug Administration (FDA) will host a webinar for device manufacturers, industry, and other interested parties to discuss and answer questions about the Clinical Laboratory Improvement Amendments (CLIA) Final Guidances:
* Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices
* Recommendations for Dual 510(k) and CLIA Waiver by Application Studies

Target Audiences: Industry, third party review organizations, technology manufacturers (including start-up companies or labs), academic and research institutions, health care facilities, professional societies, foundations and other non-profits.

To ensure you are connected, please dial in 15 minutes prior to the start of the webinar.

U.S. Callers Dial: 888-390-1068
Conference Number: PWXW9502204
Passcode: 6352340

International Callers Dial: 1-212-547-0152
Conference Number: PWXW9502204
Passcode: 6352340

To view the slide presentation during the webinar: https://www.mymeetings.com/nc/join.php?i=PWXW9502204&p=6352340&t=c

Following the webinar, a transcript, recording and slides will be available at: http://www.fda.gov/CDRHWebinar

Event Cost: 
Free